Rights offering oversubscribed at 104.29%
-
Rights offering subscription result: 17,552,147 shares subscribed vs. 16,830,200 offered (subscription rate 104.29%)
-
Existing shareholders: 14,964,975 shares; oversubscription: 2,587,172 shares (allocation ratio 0.7209512935 per share)
-
Odd shares (6,781) acquired by lead underwriter (no general public offering)
-
New shares listing date: June 8, 2026
KOSDAQ Filing Information
-
Filing: Subscription Results of Capital Increase or Equity-Linked Bonds, Etc. (Voluntary Disclosure)
-
Company: ImmuneOncia Therapeutics (424870)
-
Submission: ImmuneOncia Therapeutics, Inc.
-
Receipt: 05-15-2026
-
Under KRX KOSDAQ Market Division